Shares of Udg Healthcare PLC (LON:UDG) have been given an average recommendation of “Buy” by the six ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is GBX 622.50 ($8.87).

Shares of Udg Healthcare PLC (LON:UDG) traded up 1.87% during midday trading on Wednesday, hitting GBX 544.50. The stock had a trading volume of 424,476 shares. The stock’s 50 day moving average price is GBX 564.65 and its 200 day moving average price is GBX 520.31. Udg Healthcare PLC has a 12 month low of GBX 385.99 and a 12 month high of GBX 602.50. The firm’s market cap is GBX 1.33 billion.

In other Udg Healthcare PLC news, insider Ralph,Alan sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, December 16th. The stock was sold at an average price of GBX 577 ($8.22), for a total value of £288,500 ($411,027.21). Also, insider FitzGerald,Liam sold 272,563 shares of the firm’s stock in a transaction dated Tuesday, December 8th. The stock was sold at an average price of GBX 547 ($7.79), for a total value of £1,490,919.61 ($2,124,119.69).

UDG has been the subject of several analyst reports. Berenberg Bank restated a “hold” rating and set a GBX 515 ($7.34) price target on shares of Udg Healthcare PLC in a report on Friday, October 16th. Jefferies Group dropped their price objective on Udg Healthcare PLC from GBX 600 ($8.55) to GBX 590 ($8.41) and set a “buy” rating on the stock in a research report on Wednesday, November 4th. N+1 Singer reaffirmed a “buy” rating and set a GBX 615 ($8.76) price objective on shares of Udg Healthcare PLC in a research report on Tuesday, November 24th. Finally, Davy Research reaffirmed an “outperform” rating on shares of Udg Healthcare PLC in a research report on Thursday, November 19th.

UDG Healthcare plc is an Ireland-based provider of services to healthcare industry. The Company is a provider of outsourced commercialization solutions to healthcare companies. The Company operates in three segments: Ashfield Commercial & Medical Services, Supply Chain Services and Sharp Packaging Services. The Ashfield Commercial & Medical Services segment provides sales and marketing services (LON:UDG), healthcare communications, event management, and medical affairs and regulatory services to healthcare manufacturers, and engaged in the provision of outsourced multi-channel communications. The Supply Chain Services segment combines all of the Group’s healthcare logistics based businesses. The Sharp Packaging Services segment provides outsourced commercial and clinical trial packaging services to healthcare companies. The Company operates in four geographical regions, which include the Republic of Ireland, the United Kingdom, North America and Continental Europe.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.